PDI Antibodies

Santa Cruz Biotechnology features a diverse variety of PDI monoclonal antibodies for advanced research in protein disulfide isomerase (PDI) studies. PDI Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Protein disulfide isomerase plays a crucial role in the formation and rearrangement of disulfide bonds in proteins, which is essential for proper protein folding and stability. PDI is involved in various cellular processes, including the regulation of apoptosis and the response to oxidative stress, making it a significant target for understanding numerous diseases, including cancer and neurodegenerative disorders. The study of PDI is vital for elucidating mechanisms of protein misfolding and the development of therapeutic strategies. PDI research has revealed important insights into cellular stress responses and protein quality control mechanisms. Understanding PDI function has opened new avenues for therapeutic interventions in various pathological conditions. Research utilizing PDI monoclonal antibodies continues to advance our understanding of protein folding dynamics and cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of protein disulfide isomerase and its role in human health.